Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reprocessors unite amid rising scrutiny

This article was originally published in The Gray Sheet

Executive Summary

Alliance Medical and Vanguard Medical Concepts, two of the three major U.S. device reprocessors, officially merged Dec. 19. The combined entities will improve product offerings and increase client savings, the companies say (1"The Gray Sheet" Aug. 22, 2005, p. 12). However, government scrutiny of the industry has increased since the deal was proposed in August. In separate letters dated Dec. 16, House Government Reform Committee Chairman Tom Davis (R-VA) and Ranking Member Henry Waxman (D-CA) asked the Government Accountability Office to investigate the industry and gave FDA a Jan. 3 deadline to provide detailed information about the regulation of reprocessed devices. The congressmen were reacting to a Dec. 11-12 series in The Washington Post questioning the safety of reprocessed single-use devices (2"The Gray Sheet" Dec. 19, 2005, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel